Scantibodies Laboratory
Private Company
Funding information not available
Overview
Scantibodies Laboratory is a long-established, family-owned biotech firm with over 45 years of operational history, positioning itself as a strategic manufacturing partner for the global diagnostics industry. The company boasts significant scale with 1 million square feet of owned manufacturing and warehouse space, a workforce of approximately 500, and a proven track record in high-volume production, having manufactured 1.25 million COVID tests per day. Its vertically integrated model, from raw material production (antibodies, serum) to finished kit assembly, lyophilization, and distribution, provides a unique, full-service offering for IVD developers seeking to outsource manufacturing and logistics.
Technology Platform
Vertically integrated platform for immunodiagnostics, specializing in large-scale antibody production, heterophilic blocking reagents (HBR), lyophilization, and full-service contract manufacturing and logistics for IVD products.
Opportunities
Risk Factors
Competitive Landscape
Scantibodies competes with other large CDMOs and specialty reagent suppliers in the diagnostics space. Its key differentiators are its rare vertical integration (owning logistics), deep expertise in antibody production and interference blocking, massive owned physical infrastructure, and long-term stability as a privately held company with a single-minded focus on diagnostics manufacturing.